blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1467207

EP1467207 - Screening method for a prophylactic and therapeutic substance for a renal disease. [Right-click to bookmark this link]
Former [2004/42]SCREENING METHOD
[2007/48]
StatusNo opposition filed within time limit
Status updated on  10.04.2009
Database last updated on 02.09.2024
Most recent event   Tooltip30.09.2011Lapse of the patent in a contracting state
New state(s): CY, TR		published on 02.11.2011  [2011/44]
Applicant(s)For all designated states
Takeda Pharmaceutical Company Limited
1-1, Doshomachi 4-chome, Chuo-ku
Osaka / JP
[2008/23]
Former [2005/01]For all designated states
Takeda Pharmaceutical Company Limited
1-1, Doshomachi 4-chome Chuo-ku
Osaka / JP
Former [2004/42]For all designated states
Takeda Chemical Industries, Ltd.
1-1 Doshomachi 4-chome, Chuo-ku
Osaka-shi, Osaka 541-0045 / JP
Inventor(s)01 / NODA, Masakuni
8-7, Nakayamadera 3-chome
Takarazuka-shi, Hyogo 665-0861 / JP
02 / MATSUO, Takanori
3-21, Midorigaoka 1-chome
Ikeda-shi, Osaka 563-0026 / JP
03 / TSUGE, Hiroko
17-10-708, Oyacho
Nishinomiya-shi, Hyogo 663-8106 / JP
 [2004/42]
Representative(s)Rickard, Timothy Mark Adrian, et al
TGRD (Europe)
Intellectual Property Department
61 Aldwych
London WC2B 4AE / GB
[N/P]
Former [2004/42]Rickard, Timothy Mark Adrian, et al
Takeda Euro IP Department, 11-12 Charles II Street
London SW1Y 4QU / GB
Application number, filing date03701036.009.01.2003
[2004/42]
WO2003JP00111
Priority number, dateJP2002000376910.01.2002         Original published format: JP 2002003769
[2004/42]
Filing languageJA
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO03060516
Date:24.07.2003
Language:EN
[2003/30]
Type: A1 Application with search report 
No.:EP1467207
Date:13.10.2004
Language:EN
The application published by WIPO in one of the EPO official languages on 24.07.2003 takes the place of the publication of the European patent application.
[2004/42]
Type: B1 Patent specification 
No.:EP1467207
Date:04.06.2008
Language:EN
[2008/23]
Search report(s)International search report - published on:JP24.07.2003
(Supplementary) European search report - dispatched on:EP27.04.2006
ClassificationIPC:G01N33/68, G01N33/50
[2007/48]
CPC:
C07K14/4702 (EP,US); C12N15/113 (EP,US); G01N33/6893 (EP,US);
C12N2310/11 (EP,US); G01N2500/04 (EP,US); G01N2800/042 (EP,US)
Former IPC [2006/22]G01N33/68, C07K16/18, A61K48/00
Former IPC [2004/42]G01N33/50, G01N33/15, C07K16/18, A61K45/00, A61K48/00
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   SI,   SK,   TR [2004/42]
Extension statesALNot yet paid
LTNot yet paid
LVNot yet paid
MKNot yet paid
RONot yet paid
TitleGerman:Screening-verfahren für eine prophylaktische und therapeutische Substanz für eine Nierenerkrankung[2007/48]
English:Screening method for a prophylactic and therapeutic substance for a renal disease.[2007/48]
French:Méthode de criblage pour un composé prophylactique et thérapeutique pour une maladie rénale.[2007/48]
Former [2004/42]SCREENING-VERFAHREN
Former [2004/42]SCREENING METHOD
Former [2004/42]METHODE DE CRIBLAGE
Entry into regional phase23.07.2004Translation filed 
23.07.2004National basic fee paid 
23.07.2004Search fee paid 
23.07.2004Designation fee(s) paid 
23.07.2004Examination fee paid 
Examination procedure12.02.2003Request for preliminary examination filed
International Preliminary Examining Authority: JP
23.07.2004Examination requested  [2004/42]
04.10.2006Despatch of a communication from the examining division (Time limit: M06)
04.04.2007Reply to a communication from the examining division
17.08.2007Despatch of a communication from the examining division (Time limit: M02)
28.09.2007Reply to a communication from the examining division
07.11.2007Communication of intention to grant the patent
05.03.2008Fee for grant paid
05.03.2008Fee for publishing/printing paid
Opposition(s)05.03.2009No opposition filed within time limit [2009/20]
Fees paidRenewal fee
23.07.2004Renewal fee patent year 03
12.01.2006Renewal fee patent year 04
12.01.2007Renewal fee patent year 05
14.01.2008Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT04.06.2008
BE04.06.2008
CY04.06.2008
CZ04.06.2008
DK04.06.2008
EE04.06.2008
FI04.06.2008
IT04.06.2008
NL04.06.2008
SI04.06.2008
SK04.06.2008
TR04.06.2008
BG04.09.2008
SE04.09.2008
GR05.09.2008
ES15.09.2008
PT04.11.2008
IE09.01.2009
LU09.01.2009
MC31.01.2009
[2011/43]
Former [2011/21]AT04.06.2008
BE04.06.2008
CZ04.06.2008
DK04.06.2008
EE04.06.2008
FI04.06.2008
IT04.06.2008
NL04.06.2008
SI04.06.2008
SK04.06.2008
BG04.09.2008
SE04.09.2008
GR05.09.2008
ES15.09.2008
PT04.11.2008
IE09.01.2009
LU09.01.2009
MC31.01.2009
Former [2010/48]AT04.06.2008
BE04.06.2008
CZ04.06.2008
DK04.06.2008
EE04.06.2008
FI04.06.2008
IT04.06.2008
NL04.06.2008
SI04.06.2008
SK04.06.2008
BG04.09.2008
SE04.09.2008
GR05.09.2008
ES15.09.2008
PT04.11.2008
IE09.01.2009
MC31.01.2009
Former [2010/07]AT04.06.2008
BE04.06.2008
CZ04.06.2008
DK04.06.2008
EE04.06.2008
FI04.06.2008
IT04.06.2008
NL04.06.2008
SI04.06.2008
SK04.06.2008
BG04.09.2008
SE04.09.2008
ES15.09.2008
PT04.11.2008
IE09.01.2009
MC31.01.2009
Former [2009/39]AT04.06.2008
BE04.06.2008
CZ04.06.2008
DK04.06.2008
EE04.06.2008
FI04.06.2008
IT04.06.2008
NL04.06.2008
SI04.06.2008
SK04.06.2008
BG04.09.2008
SE04.09.2008
ES15.09.2008
PT04.11.2008
MC31.01.2009
Former [2009/23]AT04.06.2008
BE04.06.2008
CZ04.06.2008
DK04.06.2008
EE04.06.2008
FI04.06.2008
NL04.06.2008
SI04.06.2008
SK04.06.2008
BG04.09.2008
SE04.09.2008
ES15.09.2008
PT04.11.2008
Former [2009/22]AT04.06.2008
BE04.06.2008
CZ04.06.2008
DK04.06.2008
EE04.06.2008
FI04.06.2008
NL04.06.2008
SI04.06.2008
SK04.06.2008
SE04.09.2008
ES15.09.2008
PT04.11.2008
Former [2009/20]AT04.06.2008
BE04.06.2008
CZ04.06.2008
DK04.06.2008
FI04.06.2008
NL04.06.2008
SI04.06.2008
SK04.06.2008
SE04.09.2008
ES15.09.2008
PT04.11.2008
Former [2009/14]AT04.06.2008
BE04.06.2008
CZ04.06.2008
FI04.06.2008
NL04.06.2008
SI04.06.2008
SK04.06.2008
SE04.09.2008
ES15.09.2008
PT04.11.2008
Former [2009/12]AT04.06.2008
BE04.06.2008
CZ04.06.2008
FI04.06.2008
NL04.06.2008
SI04.06.2008
SE04.09.2008
ES15.09.2008
PT04.11.2008
Former [2009/07]AT04.06.2008
FI04.06.2008
NL04.06.2008
SI04.06.2008
SE04.09.2008
ES15.09.2008
Former [2009/01]AT04.06.2008
FI04.06.2008
NL04.06.2008
SI04.06.2008
ES15.09.2008
Former [2008/50]AT04.06.2008
FI04.06.2008
SI04.06.2008
ES15.09.2008
Former [2008/48]SI04.06.2008
ES15.09.2008
Former [2008/47]ES15.09.2008
Documents cited:Search[X]WO8909777  (ARCH DEV CORP [US]) [X] 23,24,26,27 * page 4, line 11 - line 22 * * page 5, line 43 - line 46 * * page 6, line 25 - line 29 * * page 7, line 25 - line 38 * * page 8, line 10 - line 14 * * page 22, line 46 - line 48 * * examples 4,8 * * claims 1,3,24-32 * * figure 1A *;
 [XY]WO0104356  (GENE LOGIC INC [US], et al) [X] 1-3,7-11,14,15,20,34,35 * abstract * * page 1, line 8 - line 9 * * page 4, line 4 - line 5 * * page 6, line 7 - line 26 * * page 9, line 3 - line 5 * * page 11, line 19 - line 23 * * page 12, line 15 - line 16 * * page 15, line 3 - line 10 * * page 15, line 21 - page 16, line 5 * * page 17, line 10 - line 20 * * examples 3-5 * * claim 7 * * sequence 1 * * idem * [Y] 4-6,16-19;
 [Y]WO0130394  (UNISEARCH LTD [AU], et al) [Y] 16 * abstract * * page 4, line 28 - line 31 * * table 1 ** claim 25 *;
 [XY]  - RUPPRECHT H D ET AL, "Expression of the transcriptional regulator Egr-1 in experimental glomerulonephritis: requirement for mesangial cell proliferation", KIDNEY INTERNATIONAL, NEW YORK, NY, US, (1997), vol. 51, no. 3, ISSN 0085-2538, pages 694 - 702, XP008029558 [X] 12,13,21,22,25,32,33 * abstract * * page 694, column 1, line 1 - line 8 * * page 695, column 1, paragraph 2 * * figures 4-6 * * table 1 * * page 699, column 1, paragraph 1 * * page 701, column 2, line 19 - line 25 * * Idem * [Y] 4-6,17-19

DOI:   http://dx.doi.org/10.1038/ki.1997.100
 [X]  - SWIRNOFF ALEXANDER H ET AL, "DNA-binding specificity of NGFI-A and related zinc finger transcription factors", MOLECULAR AND CELLULAR BIOLOGY, (1995), vol. 15, no. 4, ISSN 0270-7306, pages 2275 - 2287, XP002376477 [X] 28-31 * page 2275, column 2, lines 4-7,20-22,29-33 * * page 2276, column 2, lines 31-33 * * figures 1A,2 *
International search[A]WO8909777  (ARCH DEV CORP [US]);
 [A]WO9423030  (ARCH DEV CORP [US]);
 [X]WO9962561  (GLAXO GROUP LTD [GB], et al);
 [X]US6008048  (MONIA BRETT P [US], et al);
 [X]JP2000506725  ;
 [A]WO0104356  (GENE LOGIC INC [US], et al);
 [A]WO0174298  (BROWN UNIVERSITY RESEACH FOUND [US], et al);
 [X]  - POPOU B., KACZMARER L., BIOCHEMISTRY AND MOLECULAR BIOLOGY INTERNATIONAL, (1994), vol. 32, no. 1, pages 39 - 47, XP002967748
by applicant   - NATURE MEDICINE, vol. 6, no. 12, page 1355
    - Haruaki Yajima and Shunpei Sakakibara: Seikagaku Jikken Koza (Biochemical Experiment) 1, Tanpakushitsu no Kagaku (Chemistry of Proteins) 4, 205 (1977);
    - PROC.NATL.ACAD.SCI. USA, (1998), vol. 95, pages 8298 - 8303
    - Haruaki Yajima, ed.: Zoku Iyakuhin no Kaihatsu (A sequel to Development of Pharmaceuticals), Vol. 14, Peptide Synthesis, published by Hirokawa Shoten.
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.